Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.20p
   
  • Change Today:
      0.050p
  • 52 Week High: 11.85
  • 52 Week Low: 3.82
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,526,850
  • Market Cap: £22.40m

Eden Research fungicide wins Spain approval

By Josh White

Date: Monday 22 Feb 2016

LONDON (ShareCast) - (ShareCast News) - Eden Research took its vineyard-saving fungicide to another of the world's largest wine producers on Monday, with authorisation from Spanish authorities for the use of 3AEY in the country.
The AIM-traded microencapsulation technology company said 3AEY would be sold in Spain by partner Sipcam Iberia, under the trade name ARAW, with Eden receiving royalties from sales.

Directors described the deal as another significant milestone, allowing it to access the third largest wine producer in the world. The approval came in time for the 2016 growing season, and followed hot on the heels of approval in Italy, announced on 11 February.

3AEY is now approved for sale in Kenya, Malta, Greece, Bulgaria, Italy and Spain.

"Sipcam has already initiated pre-marketing efforts and is now able to pursue full product launch for ARAW in time for this year's growing season," said Eden chief executive Sean Smith.

"Going forward, we will continue to work with Sipcam to support the further development of 3AEY for non-grape crops through the label extension process. Furthermore, we are also working together to explore the potential to develop 3AEY for the treatment of other fungal pathogens on grapes and other high-value fruits and vegetables," he added.

3AEY was a terpene-based fungicide specifically targeting botrytis, a fungal disease that caused grey mould on a number of fruits and vegatabled. Botrytis can destroy up to 30% of a vineyard in a matter of days if left untreated, the company said.

Shares in Eden were 15% higher at 14.06p by noon on Monday.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.20p
Change Today 0.050p
% Change 1.20 %
52 Week High 11.85
52 Week Low 3.82
Volume 1,526,850
Shares Issued 533.35m
Market Cap £22.40m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average17.37% below the market average
29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average29.41% below the sector average
Price Trend
21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average21.6% below the market average
16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average16.98% above the sector average
Income Not Available
Growth
49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average49.00% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

Eden Research Dividends

No dividends found

Trades for 14-Jun-2024

Time Volume / Share Price
15:59 596,915 @ 4.40p
15:05 459,563 @ 4.35p
14:52 7,933 @ 4.08p
14:46 12,737 @ 4.08p
14:37 13,833 @ 3.82p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page